DrugPatentWatch Database Preview
Meridian Medcl Company Profile
What is the competitive landscape for MERIDIAN MEDCL, and what generic alternatives to MERIDIAN MEDCL drugs are available?
MERIDIAN MEDCL has seven approved drugs.
There is one US patent protecting MERIDIAN MEDCL drugs.
There are four patent family members on MERIDIAN MEDCL drugs in four countries.
Summary for Meridian Medcl
| International Patents: | 4 |
| US Patents: | 1 |
| Tradenames: | 7 |
| Ingredients: | 7 |
| NDAs: | 7 |
Drugs and US Patents for Meridian Medcl
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Meridian Medcl Techn | PRALIDOXIME CHLORIDE | pralidoxime chloride | INJECTABLE;INJECTION | 018986-001 | Apr 26, 1983 | RX | Yes | Yes | Start Trial | Start Trial | |||||
| Meridian Medcl Techn | SEIZALAM | midazolam hydrochloride | SOLUTION;INTRAMUSCULAR | 209566-001 | Sep 14, 2018 | RX | Yes | Yes | Start Trial | Start Trial | |||||
| Meridian Medcl | ALSUMA | sumatriptan succinate | INJECTABLE;SUBCUTANEOUS | 022377-001 | Jun 29, 2010 | DISCN | No | No | 7,811,254 | Start Trial | Y | Start Trial | |||
| Meridian Medcl Techn | ATROPEN | atropine | SOLUTION;INTRAMUSCULAR | 017106-002 | Jun 19, 2003 | RX | Yes | Yes | Start Trial | Start Trial | |||||
| Meridian Medcl Techn | ATROPEN | atropine | SOLUTION;INTRAMUSCULAR | 017106-004 | Sep 17, 2004 | RX | Yes | Yes | Start Trial | Start Trial | |||||
| Meridian Medcl Techn | LIDOPEN | lidocaine hydrochloride | INJECTABLE;INJECTION | 017549-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | Start Trial | Start Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Meridian Medcl
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Meridian Medcl | DUODOTE | atropine; pralidoxime chloride | INJECTABLE;INTRAMUSCULAR | 021983-001 | Sep 28, 2006 | 5,092,843 | Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for Meridian Medcl Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| World Intellectual Property Organization (WIPO) | 2008048750 | Start Trial |
| European Patent Office | 2073866 | Start Trial |
| Canada | 2666860 | Start Trial |
| Taiwan | 200838574 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
